Marcenett De Los Angeles Villegas Ovares
Sanctions
—
Adverse media
—
Charges
Public charges
- CRI
- CRI
- CRI
Relationships
—
Adverse info
—
Frequently Asked Questions
1. Does Marcenett De Los Angeles Villegas Ovares have any sanctions?
No, Marcenett De Los Angeles Villegas Ovares currently has no sanctions but might have them in the future. Would you like to receive an alert?
2. Is Marcenett De Los Angeles Villegas Ovares a PEP (Politically Exposed Person)?
Yes, Marcenett De Los Angeles Villegas Ovares is considered a PEP under the following countries' regulations: Costa Rica , Costa Rica , Costa Rica .
3. What is the relationship between Marcenett De Los Angeles Villegas Ovares and the AML regulation in Costa Rica?
Marcenett De Los Angeles Villegas Ovares is a relevant person under Costa Rica's AML regulation because they are or were considered a Politically Exposed Person.
4. What is the relationship between Marcenett De Los Angeles Villegas Ovares and the AML regulation in Costa Rica?
Marcenett De Los Angeles Villegas Ovares is a relevant person under Costa Rica's AML regulation because they are or were considered a Politically Exposed Person.
5. What is the relationship between Marcenett De Los Angeles Villegas Ovares and the AML regulation in Costa Rica?
Marcenett De Los Angeles Villegas Ovares is a relevant person under Costa Rica's AML regulation because they are or were considered a Politically Exposed Person.
6. Can I receive automatic alerts about PEPs (Politically Exposed Person)?
Yes, Pibisi collects PEP lists from multiple sources and official websites, helping you monitor your clients, investors, or persons of interest.
7. Where does this information come from?
Pibisi's proprietary AML database gathers all of its information from public, official, online AML lists and institutional websites. These are the sources that contain information about Marcenett De Los Angeles Villegas Ovares:
| Name | Info | Source |
|---|---|---|
| Web del Tribunal Supremo de elecciones de la República de Costa Rica | PEPs | CRI |